Table of Contents
respect to achieving certain corporate goals or to reward executives for exceptional performance.
to this offering, except as described below for certain transactions with Mr. Carbona, we have granted all equity awards pursuant to the 2014 Plan the terms of which are
described below under " Equity Benefit Plans." All options are granted with a per share exercise price equal to no less than the fair market value of a share of our common stock on the
date of the grant of such award.
June 2015, our compensation committee awarded Mr. Nolan an option to purchase 738,300 shares of our common stock at an exercise price of $15.94 per share. In
August 2015, our compensation committee awarded Mr. Dee an option to purchase 164,059 shares of our common stock at an exercise price of $18.17 per share. In October 2015, our compensation
committee awarded Dr. Nagendran an option to purchase 199,855 shares of our common stock at an exercise price of $18.48 per share. See " Outstanding Equity Awards at
December 31, 2015" for more information regarding these grants. In addition to equity award grants under the 2014 Plan, Mr. Carbona was party to a number of transactions with us and
entities affiliated with us that may be considered compensatory in nature and which, for accounting purposes, we have accounted for as stock-based compensation in our consolidated statements included
in this prospectus.
In January 2014, we entered into an exchange agreement with Mr. Carbona under which Mr. Carbona exchanged 202,347 common
shares held by him for 202,347 Class B-1 preferred shares for no additional consideration.
In January 2014, JDH Investment Management, LLC, or JDH Investment, an entity controlled by Mr. Harkey, West Summit
Investments, LP, or West Summit, an entity controlled by Dr. Genecov, and Mr. Carbona entered into a Stock Purchase and Option Agreement. Under the agreement, JDH Investment and
West Summit sold an aggregate of 392,287 common shares to Mr. Carbona for the price per share of $0.00007, or $28.44 in the aggregate. Additionally, the agreement contained a cross option,
which provided Mr. Carbona the right to buy one-third of any eligible shares acquired in the future by JDH Investment or West Summit for the price paid by them to acquire the shares, and
provided each of JDH Investment and West Summit an option to buy one-third of any eligible shares acquired in the future by Mr. Carbona for the price paid by him to acquire the shares. Under
the agreement, the cross option would only terminate upon a reorganization or merger of the company, a sale of substantially all of the assets of the company or an initial public offering. During
2014, there were no exercises by any party of the cross option. However, in connection with the termination of Mr. Carbona's employment in April 2015, the parties entered into a Mutual
Termination Agreement, under which Mr. Carbona transferred one-third of his June 2014 option grant described below to each of JDH Investment and West Summit and the parties agreed to terminate
the cross option.
treated the shares sold to Mr. Carbona pursuant to the Stock Purchase and Option Agreement as stock-based compensation under ASC 718. As the shares sold to Mr. Carbona
pursuant to the Stock Purchase and Option Agreement were fully vested on the date of the purchase and there was no service to be performed by Mr. Carbona in order to retain the shares, the
shares do not appear in the "Outstanding Equity Awards at December 31, 2015" table below.
In June 2014, we granted Mr. Carbona an option to purchase an aggregate of 207,000 shares of common stock under our 2014 Plan.
The option was an incentive stock option with respect to